Personalized Medication  Technology Trend Analysis (Technical Insights)

 

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

This research service analyzes emerging technologies in personalized medicine and their impact on the healthcare market.

Table of Contents

Personalized Medication – Technology Trend Analysis (Technical Insights), Executive SummaryIntroductionIntroduction to Personalized MedicationSynopsis of Key Findings and Technological TrendsScope and MethodologyScope and Segmentation of the Research ServiceMethodologyPersonalized Medication – Technology Trend Analysis (Technical Insights), Personalized Medicine in Prophylactic TreatmentTechnology Primer and Key Findings Technology PrimerKey FindingsNoteworthy Innovations in Companies and UniversitiesNew Methods to Detect PCR SNPs and Genetic Variation/Mutation--UKGenetic Studies in DNP to Help Individualize the Care of Patients with Diabetes--USAStudy of an EFGR Mutant to Play Important Role in Signaling Pathways Leading to Cancer--USAPrognostic Marker for Staging Multiple Sclerosis Patients--IsraelPersonalized Medication – Technology Trend Analysis (Technical Insights), Personalized Medication in TherapeuticsTechnology Primer and Key FindingsTechnology PrimerKey FindingsNoteworthy Innovations in Companies and UniversitiesGenetic Profile of EE to Help in Developing New Ways of Therapeutics--USAGene Expression Pattern to Improve Diagnosis and Treatment of Interstitial Lung Disease--USAAssay for Targeted Cancer Therapy--USANovel Method for Targeted Therapy in Non-Small Cell Lung Cancer--USAPersonalized Medicine in Psychiatry--IsraelPersonalized Medication – Technology Trend Analysis (Technical Insights), Diagnostics in Personalized MedicationTechnology Primer and Key FindingsTechnology PrimerKey FindingsNoteworthy Innovations in Companies and UniversitiesA Single Diagnostic Assay to Analyze Complex Genetic Information -GermanyAn Innovative Gene Mapping Technology to Develop Diagnostic Genetic Tests--FranceA Diagnostic Assay Helps Identify Genetic Polymorphism in Patients with Metastatic Colorectal Cancer--USABiomarkers To Be Used in Protein Molecular Diagnostic Tests--UKLipoprotein Biomarkers for Atherosclerosis--USAA Powerful Genomics Discovery Technology Platform--USACSF Biomarkers for Frontotemporal Degeneration--USAPersonalized Medication – Technology Trend Analysis (Technical Insights), Software in Personalized MedicineTechnology Primer and Key FindingsTechnology PrimerKey FindingsNoteworthy Innovations in Companies and UniversitiesBiosimulation Software to Dynamics of Biological Processes Related to Cancer Progression--IsraelFirst Powerful Platform to Automate Experiments and Manage Data in Laboratories--USABioBanks to Serve as Interaction Points between Genes; Lifestyle; and Disease--USAPersonalized Medication – Technology Trend Analysis (Technical Insights), Technology Adoption Factor AnalysisTechnology Challenges; Accelerators; and RoadblocksChallengesAcceleratorsRoadblocksFuture of Personalized Medication; Venture Capital Space; Mergers and AcquisitionsFuture of Personalized MedicationVenture Capital Space and Insurance PoliciesMerger and AcquisitionsPersonalized Medication – Technology Trend Analysis (Technical Insights), Patents and Key ContactsPatentsPatents in Prophylactic TreatmentPatents Related to TherapeuticsPatents Related to DiagnosticsContact DetailsCompany ContactsUniversity ContactsPersonalized Medication – Technology Trend Analysis (Technical Insights), Frost & Sullivan 2006 Science and Technology AwardsExcellence in Technology AwardAward DescriptionAward RecipientTechnology Innovation AwardAward DescriptionAward RecipientProduct Innovation AwardAward DescriptionAward RecipientPersonalized Medication – Technology Trend Analysis (Technical Insights), Decision Support DatabaseDatabase TablesIncidence of Breast Cancer (1999-2006)Incidence of Colon Rectum Cancer (1999-2006)Incidence of Lung Cancer (1999-2006)Incidence of Prostate Cancer (1999-2006)Prevalence of Diabetes (1999-2006) Percentage of Pharma R&D Expenses (1999-2006)




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 10-Nov-17

Region : Global

Release Date : 10-Nov-17

Region : Global

Release Date : 09-Nov-17

Region : Global

Release Date : 03-Nov-17

Region : Global

Release Date : 31-Oct-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.